Biogen Inc. Global Phase 3 Overlap Study Evaluates the Efficacy and Safety of Ferzaltamab compared to placebo in adults with delayed AMR AMR is the main cause of kidney transplant …
phase
-
Kidney Transplantation
-
Diet
Standardized Phase Angle for Predicting Nutritional Status of Hemodialysis Patients in the Early Period After Deceased Donor Kidney Transplantation
by News Sourceby News SourceIntroduction Kidney transplantation is considered as the optimal treatment option for end-stage kidney disease. It enables greater longevity and better quality of life compared to peritoneal dialysis and hemodialysis (1, …
-
Kidney Transplantation
HI-Bio Announces Positive Results from Phase 2 Study of Felzalutamab for Late Antibody-Mediated Rejection in Kidney Transplant Patients
by HI-Bioby HI-Bio82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …
-
Dialysis
IL-6 inhibition with clazakizumab in patients undergoing maintenance dialysis: a randomized phase 2b study.
Competing interests GMC serves on the board of directors of Satellite Healthcare, a not-for-profit dialysis provider. His institution (Stanford University) has received grant funding from clinical trial sponsor CSL Behring. …
-
Lung Transplantation
TFF Pharmaceuticals Announces Interim Data from a Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) to Prevent Lung Transplant Rejection at the 44th International Society for Heart and Lung Transplantation (ISHLT) 2024 Annual Meeting
TFF Pharma Co., Ltd. Oral Presentation Presenting Latest Data from a Phase 2 Study Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TAC FORT WORTH, Texas, March 25, …
-
News
Eledon Pharmaceuticals Announces Enrollment of 12th Participant in Phase 2 BESTOW Study Evaluating Tegopulvert for Prevention of Organ Rejection
Eredon Pharmaceuticals Co., Ltd. IRVINE, Calif., March 25, 2024 (Globe Newswire) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the registration of 12 pharmaceutical companies.th On March 23, 2024, …
-
Bone marrow transplantion
Tonix Pharmaceuticals completes Phase 1 clinical trial of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody) in healthy volunteers
Tonix Pharmaceuticals Holding Co., Ltd. Top-line results are expected in the third quarter of 2024.Planning phase 2 trial to prevent kidney transplant rejection Anti-CD40L has multiple potential indications in addition …
-
Diet
Association of sarcopenia with phase angle and body mass index in kidney transplant recipients
by Junji Uchidaby Junji UchidaLaupacis, A. et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 50, 235â242 (1996). Article CAS PubMed Google Scholar Wolfe, R. A. et …